Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer

There is an increasing demand for accurate biomarkers for early non-invasive colorectal cancer detection. We employed a genome-scale marker discovery method to identify and verify candidate DNA methylation biomarkers for blood-based detection of colorectal cancer. We used DNA methylation data from 7...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2012-11, Vol.7 (11), p.e50266-e50266
Hauptverfasser: Lange, Christopher P E, Campan, Mihaela, Hinoue, Toshinori, Schmitz, Roderick F, van der Meulen-de Jong, Andrea E, Slingerland, Hilde, Kok, Peter J M J, van Dijk, Cornelis M, Weisenberger, Daniel J, Shen, Hui, Tollenaar, Robertus A E M, Laird, Peter W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e50266
container_issue 11
container_start_page e50266
container_title PloS one
container_volume 7
creator Lange, Christopher P E
Campan, Mihaela
Hinoue, Toshinori
Schmitz, Roderick F
van der Meulen-de Jong, Andrea E
Slingerland, Hilde
Kok, Peter J M J
van Dijk, Cornelis M
Weisenberger, Daniel J
Shen, Hui
Tollenaar, Robertus A E M
Laird, Peter W
description There is an increasing demand for accurate biomarkers for early non-invasive colorectal cancer detection. We employed a genome-scale marker discovery method to identify and verify candidate DNA methylation biomarkers for blood-based detection of colorectal cancer. We used DNA methylation data from 711 colorectal tumors, 53 matched adjacent-normal colonic tissue samples, 286 healthy blood samples and 4,201 tumor samples of 15 different cancer types. DNA methylation data were generated by the Illumina Infinium HumanMethylation27 and the HumanMethylation450 platforms, which determine the methylation status of 27,578 and 482,421 CpG sites respectively. We first performed a multistep marker selection to identify candidate markers with high methylation across all colorectal tumors while harboring low methylation in healthy samples and other cancer types. We then used pre-therapeutic plasma and serum samples from 107 colorectal cancer patients and 98 controls without colorectal cancer, confirmed by colonoscopy, to verify candidate markers. We selected two markers for further evaluation: methylated THBD (THBD-M) and methylated C9orf50 (C9orf50-M). When tested on clinical plasma and serum samples these markers outperformed carcinoembryonic antigen (CEA) serum measurement and resulted in a high sensitive and specific test performance for early colorectal cancer detection. Our systematic marker discovery and verification study for blood-based DNA methylation markers resulted in two novel colorectal cancer biomarkers, THBD-M and C9orf50-M. THBD-M in particular showed promising performance in clinical samples, justifying its further optimization and clinical testing.
doi_str_mv 10.1371/journal.pone.0050266
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1350901218</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A477008412</galeid><doaj_id>oai_doaj_org_article_fada6eca2e264ae695fc74a84b5c1f63</doaj_id><sourcerecordid>A477008412</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758t-1f7879ce431a5a906a16c4069b4f3b8e42aeefccc28ca00585234b0d5fd3dc983</originalsourceid><addsrcrecordid>eNqNk01v1DAQhiMEoqXwDxBEQkJwyOKPxEkuSKsCZaWKSnxdrYkz3s3ixIudVOy_x-mm1Qb1QHxIYj_va894JoqeU7KgPKfvtnZwHZjFzna4ICQjTIgH0SktOUsEI_zh0fdJ9MT7bYB4IcTj6IRxRkpRstNIXWBnW0y8AoNx3Xhlr9HtY6vjD1-WSYv9Zm-gb2wXV41twf1C52NtXVwZa-ukAo91XGOP6gYKOmWNdeEXTKygU-ieRo80GI_PpvdZ9OPTx-_nn5PLq4vV-fIyUXlW9AnVeZGXClNOIYOSCKBCpUSUVap5VWDKAFErpVihIMRSZIynFakzXfNalQU_i14efHfGejnlx0vKM1ISyuhIrA5EbWErd64JAe2lhUbeTFi3luD6RhmUGmoQqIAhEymgKDOt8hSKtMoU1YIHr_fTbkPVYq2w6x2Ymel8pWs2cm2vZThOUdI8GLyZDJz9PaDvZRvSj8ZAh3YI52bh4TwVI_rqH_T-6CZqHe5SNp22YV81msplmueEFCllgVrcQ4VRY9uoUEy6CfMzwduZIDA9_unXMHgvV9--_j979XPOvj5iNwim33hrhrGO_BxMD6By1nuH-i7JlMixF26zIcdekFMvBNmL4wu6E90WP_8LZtwE7A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1350901218</pqid></control><display><type>article</type><title>Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Lange, Christopher P E ; Campan, Mihaela ; Hinoue, Toshinori ; Schmitz, Roderick F ; van der Meulen-de Jong, Andrea E ; Slingerland, Hilde ; Kok, Peter J M J ; van Dijk, Cornelis M ; Weisenberger, Daniel J ; Shen, Hui ; Tollenaar, Robertus A E M ; Laird, Peter W</creator><creatorcontrib>Lange, Christopher P E ; Campan, Mihaela ; Hinoue, Toshinori ; Schmitz, Roderick F ; van der Meulen-de Jong, Andrea E ; Slingerland, Hilde ; Kok, Peter J M J ; van Dijk, Cornelis M ; Weisenberger, Daniel J ; Shen, Hui ; Tollenaar, Robertus A E M ; Laird, Peter W</creatorcontrib><description>There is an increasing demand for accurate biomarkers for early non-invasive colorectal cancer detection. We employed a genome-scale marker discovery method to identify and verify candidate DNA methylation biomarkers for blood-based detection of colorectal cancer. We used DNA methylation data from 711 colorectal tumors, 53 matched adjacent-normal colonic tissue samples, 286 healthy blood samples and 4,201 tumor samples of 15 different cancer types. DNA methylation data were generated by the Illumina Infinium HumanMethylation27 and the HumanMethylation450 platforms, which determine the methylation status of 27,578 and 482,421 CpG sites respectively. We first performed a multistep marker selection to identify candidate markers with high methylation across all colorectal tumors while harboring low methylation in healthy samples and other cancer types. We then used pre-therapeutic plasma and serum samples from 107 colorectal cancer patients and 98 controls without colorectal cancer, confirmed by colonoscopy, to verify candidate markers. We selected two markers for further evaluation: methylated THBD (THBD-M) and methylated C9orf50 (C9orf50-M). When tested on clinical plasma and serum samples these markers outperformed carcinoembryonic antigen (CEA) serum measurement and resulted in a high sensitive and specific test performance for early colorectal cancer detection. Our systematic marker discovery and verification study for blood-based DNA methylation markers resulted in two novel colorectal cancer biomarkers, THBD-M and C9orf50-M. THBD-M in particular showed promising performance in clinical samples, justifying its further optimization and clinical testing.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0050266</identifier><identifier>PMID: 23209692</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Aged ; Biological markers ; Biology ; Biomarkers ; Biomarkers, Tumor - metabolism ; Blood ; Blood tests ; Breast cancer ; Cancer ; Cancer diagnosis ; Cancer genetics ; Cancer research ; Cancer therapies ; Carcinoembryonic antigen ; Case-Control Studies ; Cell Line, Tumor ; Colon ; Colonoscopy ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - blood ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - genetics ; CpG Islands ; Deoxyribonucleic acid ; Disease ; DNA ; DNA - genetics ; DNA Methylation ; Endoscopy ; Epigenetics ; Female ; Gastroenterology ; Gastrointestinal diseases ; Genetic aspects ; Genetic Markers - genetics ; Genome, Human ; Genomes ; Genomics ; Health aspects ; Hepatology ; Hospitals ; Humans ; Inflammatory bowel disease ; Male ; Medical prognosis ; Medical research ; Medicine ; Methylation ; Middle Aged ; Optimization ; Plasma ; Studies ; Surgery ; Surveillance ; Tumors</subject><ispartof>PloS one, 2012-11, Vol.7 (11), p.e50266-e50266</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>2012 Lange et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2012 Lange et al 2012 Lange et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c758t-1f7879ce431a5a906a16c4069b4f3b8e42aeefccc28ca00585234b0d5fd3dc983</citedby><cites>FETCH-LOGICAL-c758t-1f7879ce431a5a906a16c4069b4f3b8e42aeefccc28ca00585234b0d5fd3dc983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508917/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508917/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23209692$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lange, Christopher P E</creatorcontrib><creatorcontrib>Campan, Mihaela</creatorcontrib><creatorcontrib>Hinoue, Toshinori</creatorcontrib><creatorcontrib>Schmitz, Roderick F</creatorcontrib><creatorcontrib>van der Meulen-de Jong, Andrea E</creatorcontrib><creatorcontrib>Slingerland, Hilde</creatorcontrib><creatorcontrib>Kok, Peter J M J</creatorcontrib><creatorcontrib>van Dijk, Cornelis M</creatorcontrib><creatorcontrib>Weisenberger, Daniel J</creatorcontrib><creatorcontrib>Shen, Hui</creatorcontrib><creatorcontrib>Tollenaar, Robertus A E M</creatorcontrib><creatorcontrib>Laird, Peter W</creatorcontrib><title>Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>There is an increasing demand for accurate biomarkers for early non-invasive colorectal cancer detection. We employed a genome-scale marker discovery method to identify and verify candidate DNA methylation biomarkers for blood-based detection of colorectal cancer. We used DNA methylation data from 711 colorectal tumors, 53 matched adjacent-normal colonic tissue samples, 286 healthy blood samples and 4,201 tumor samples of 15 different cancer types. DNA methylation data were generated by the Illumina Infinium HumanMethylation27 and the HumanMethylation450 platforms, which determine the methylation status of 27,578 and 482,421 CpG sites respectively. We first performed a multistep marker selection to identify candidate markers with high methylation across all colorectal tumors while harboring low methylation in healthy samples and other cancer types. We then used pre-therapeutic plasma and serum samples from 107 colorectal cancer patients and 98 controls without colorectal cancer, confirmed by colonoscopy, to verify candidate markers. We selected two markers for further evaluation: methylated THBD (THBD-M) and methylated C9orf50 (C9orf50-M). When tested on clinical plasma and serum samples these markers outperformed carcinoembryonic antigen (CEA) serum measurement and resulted in a high sensitive and specific test performance for early colorectal cancer detection. Our systematic marker discovery and verification study for blood-based DNA methylation markers resulted in two novel colorectal cancer biomarkers, THBD-M and C9orf50-M. THBD-M in particular showed promising performance in clinical samples, justifying its further optimization and clinical testing.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological markers</subject><subject>Biology</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Blood</subject><subject>Blood tests</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Cancer diagnosis</subject><subject>Cancer genetics</subject><subject>Cancer research</subject><subject>Cancer therapies</subject><subject>Carcinoembryonic antigen</subject><subject>Case-Control Studies</subject><subject>Cell Line, Tumor</subject><subject>Colon</subject><subject>Colonoscopy</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - blood</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - genetics</subject><subject>CpG Islands</subject><subject>Deoxyribonucleic acid</subject><subject>Disease</subject><subject>DNA</subject><subject>DNA - genetics</subject><subject>DNA Methylation</subject><subject>Endoscopy</subject><subject>Epigenetics</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Gastrointestinal diseases</subject><subject>Genetic aspects</subject><subject>Genetic Markers - genetics</subject><subject>Genome, Human</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Health aspects</subject><subject>Hepatology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Inflammatory bowel disease</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Methylation</subject><subject>Middle Aged</subject><subject>Optimization</subject><subject>Plasma</subject><subject>Studies</subject><subject>Surgery</subject><subject>Surveillance</subject><subject>Tumors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk01v1DAQhiMEoqXwDxBEQkJwyOKPxEkuSKsCZaWKSnxdrYkz3s3ixIudVOy_x-mm1Qb1QHxIYj_va894JoqeU7KgPKfvtnZwHZjFzna4ICQjTIgH0SktOUsEI_zh0fdJ9MT7bYB4IcTj6IRxRkpRstNIXWBnW0y8AoNx3Xhlr9HtY6vjD1-WSYv9Zm-gb2wXV41twf1C52NtXVwZa-ukAo91XGOP6gYKOmWNdeEXTKygU-ieRo80GI_PpvdZ9OPTx-_nn5PLq4vV-fIyUXlW9AnVeZGXClNOIYOSCKBCpUSUVap5VWDKAFErpVihIMRSZIynFakzXfNalQU_i14efHfGejnlx0vKM1ISyuhIrA5EbWErd64JAe2lhUbeTFi3luD6RhmUGmoQqIAhEymgKDOt8hSKtMoU1YIHr_fTbkPVYq2w6x2Ymel8pWs2cm2vZThOUdI8GLyZDJz9PaDvZRvSj8ZAh3YI52bh4TwVI_rqH_T-6CZqHe5SNp22YV81msplmueEFCllgVrcQ4VRY9uoUEy6CfMzwduZIDA9_unXMHgvV9--_j979XPOvj5iNwim33hrhrGO_BxMD6By1nuH-i7JlMixF26zIcdekFMvBNmL4wu6E90WP_8LZtwE7A</recordid><startdate>20121128</startdate><enddate>20121128</enddate><creator>Lange, Christopher P E</creator><creator>Campan, Mihaela</creator><creator>Hinoue, Toshinori</creator><creator>Schmitz, Roderick F</creator><creator>van der Meulen-de Jong, Andrea E</creator><creator>Slingerland, Hilde</creator><creator>Kok, Peter J M J</creator><creator>van Dijk, Cornelis M</creator><creator>Weisenberger, Daniel J</creator><creator>Shen, Hui</creator><creator>Tollenaar, Robertus A E M</creator><creator>Laird, Peter W</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20121128</creationdate><title>Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer</title><author>Lange, Christopher P E ; Campan, Mihaela ; Hinoue, Toshinori ; Schmitz, Roderick F ; van der Meulen-de Jong, Andrea E ; Slingerland, Hilde ; Kok, Peter J M J ; van Dijk, Cornelis M ; Weisenberger, Daniel J ; Shen, Hui ; Tollenaar, Robertus A E M ; Laird, Peter W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758t-1f7879ce431a5a906a16c4069b4f3b8e42aeefccc28ca00585234b0d5fd3dc983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological markers</topic><topic>Biology</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Blood</topic><topic>Blood tests</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Cancer diagnosis</topic><topic>Cancer genetics</topic><topic>Cancer research</topic><topic>Cancer therapies</topic><topic>Carcinoembryonic antigen</topic><topic>Case-Control Studies</topic><topic>Cell Line, Tumor</topic><topic>Colon</topic><topic>Colonoscopy</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - blood</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - genetics</topic><topic>CpG Islands</topic><topic>Deoxyribonucleic acid</topic><topic>Disease</topic><topic>DNA</topic><topic>DNA - genetics</topic><topic>DNA Methylation</topic><topic>Endoscopy</topic><topic>Epigenetics</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Gastrointestinal diseases</topic><topic>Genetic aspects</topic><topic>Genetic Markers - genetics</topic><topic>Genome, Human</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Health aspects</topic><topic>Hepatology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Inflammatory bowel disease</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Methylation</topic><topic>Middle Aged</topic><topic>Optimization</topic><topic>Plasma</topic><topic>Studies</topic><topic>Surgery</topic><topic>Surveillance</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lange, Christopher P E</creatorcontrib><creatorcontrib>Campan, Mihaela</creatorcontrib><creatorcontrib>Hinoue, Toshinori</creatorcontrib><creatorcontrib>Schmitz, Roderick F</creatorcontrib><creatorcontrib>van der Meulen-de Jong, Andrea E</creatorcontrib><creatorcontrib>Slingerland, Hilde</creatorcontrib><creatorcontrib>Kok, Peter J M J</creatorcontrib><creatorcontrib>van Dijk, Cornelis M</creatorcontrib><creatorcontrib>Weisenberger, Daniel J</creatorcontrib><creatorcontrib>Shen, Hui</creatorcontrib><creatorcontrib>Tollenaar, Robertus A E M</creatorcontrib><creatorcontrib>Laird, Peter W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lange, Christopher P E</au><au>Campan, Mihaela</au><au>Hinoue, Toshinori</au><au>Schmitz, Roderick F</au><au>van der Meulen-de Jong, Andrea E</au><au>Slingerland, Hilde</au><au>Kok, Peter J M J</au><au>van Dijk, Cornelis M</au><au>Weisenberger, Daniel J</au><au>Shen, Hui</au><au>Tollenaar, Robertus A E M</au><au>Laird, Peter W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-11-28</date><risdate>2012</risdate><volume>7</volume><issue>11</issue><spage>e50266</spage><epage>e50266</epage><pages>e50266-e50266</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>There is an increasing demand for accurate biomarkers for early non-invasive colorectal cancer detection. We employed a genome-scale marker discovery method to identify and verify candidate DNA methylation biomarkers for blood-based detection of colorectal cancer. We used DNA methylation data from 711 colorectal tumors, 53 matched adjacent-normal colonic tissue samples, 286 healthy blood samples and 4,201 tumor samples of 15 different cancer types. DNA methylation data were generated by the Illumina Infinium HumanMethylation27 and the HumanMethylation450 platforms, which determine the methylation status of 27,578 and 482,421 CpG sites respectively. We first performed a multistep marker selection to identify candidate markers with high methylation across all colorectal tumors while harboring low methylation in healthy samples and other cancer types. We then used pre-therapeutic plasma and serum samples from 107 colorectal cancer patients and 98 controls without colorectal cancer, confirmed by colonoscopy, to verify candidate markers. We selected two markers for further evaluation: methylated THBD (THBD-M) and methylated C9orf50 (C9orf50-M). When tested on clinical plasma and serum samples these markers outperformed carcinoembryonic antigen (CEA) serum measurement and resulted in a high sensitive and specific test performance for early colorectal cancer detection. Our systematic marker discovery and verification study for blood-based DNA methylation markers resulted in two novel colorectal cancer biomarkers, THBD-M and C9orf50-M. THBD-M in particular showed promising performance in clinical samples, justifying its further optimization and clinical testing.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23209692</pmid><doi>10.1371/journal.pone.0050266</doi><tpages>e50266</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2012-11, Vol.7 (11), p.e50266-e50266
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1350901218
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Adult
Aged
Biological markers
Biology
Biomarkers
Biomarkers, Tumor - metabolism
Blood
Blood tests
Breast cancer
Cancer
Cancer diagnosis
Cancer genetics
Cancer research
Cancer therapies
Carcinoembryonic antigen
Case-Control Studies
Cell Line, Tumor
Colon
Colonoscopy
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - blood
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - genetics
CpG Islands
Deoxyribonucleic acid
Disease
DNA
DNA - genetics
DNA Methylation
Endoscopy
Epigenetics
Female
Gastroenterology
Gastrointestinal diseases
Genetic aspects
Genetic Markers - genetics
Genome, Human
Genomes
Genomics
Health aspects
Hepatology
Hospitals
Humans
Inflammatory bowel disease
Male
Medical prognosis
Medical research
Medicine
Methylation
Middle Aged
Optimization
Plasma
Studies
Surgery
Surveillance
Tumors
title Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T14%3A18%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genome-scale%20discovery%20of%20DNA-methylation%20biomarkers%20for%20blood-based%20detection%20of%20colorectal%20cancer&rft.jtitle=PloS%20one&rft.au=Lange,%20Christopher%20P%20E&rft.date=2012-11-28&rft.volume=7&rft.issue=11&rft.spage=e50266&rft.epage=e50266&rft.pages=e50266-e50266&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0050266&rft_dat=%3Cgale_plos_%3EA477008412%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1350901218&rft_id=info:pmid/23209692&rft_galeid=A477008412&rft_doaj_id=oai_doaj_org_article_fada6eca2e264ae695fc74a84b5c1f63&rfr_iscdi=true